GlassScriptPhysician profile
Justin M Tolman
NPI 1396790689
$2,768.99
in general payments reported to CMS, 2019-2025
12 companies · $626 in 2025
The $626 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $226 · 2021: $288 · 2022: $348 · 2023: $374 · 2024: $306 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195 · Entertainment: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.06 |
| Entertainment | $111.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,101.34 | 2019-2025 | Total30, Precision 1, Precision7 |
| Coopervision INC. | $359.87 | 2019-2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $315.75 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $268.32 | 2022-2025 | Infuse, Biotrue One Day |
| Optos, INC. | $256.20 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Glaukos Corporation | $95.67 | 2025 | Idosetr |
| Maculogix, INC. | $77.98 | 2019 | |
| Optovue, INC. | $72.93 | 2019 | |
| Abb Con-Cise Optical Group LLC | $71.33 | 2019-2021 | |
| Biotissue Holdings INC. | $66.91 | 2019-2023 | |
| Rxsight INC | $62.50 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Oyster Point Pharma, INC. | $20.19 | 2024 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Tolman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.